Results 211 to 216 of about 34,967 (216)

Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome

Journal of Thrombosis and Haemostasis, 2015
D A Isenberg, I J Mackie
exaly  

Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with acute coronary syndromes

British Journal of Clinical Pharmacology, 2012
Xu Steven Xu, Kenneth Moore
exaly  

Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Rivaroxaban—an Oral, Direct Factor Xa Inhibitor—Are Not Affected by Aspirin

Journal of Clinical Pharmacology, 2006
exaly  

Co‐administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects

British Journal of Clinical Pharmacology, 2013
exaly  

Measurement of rivaroxaban and apixaban in serum samples of patients

European Journal of Clinical Investigation, 2014
exaly  

Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays

Journal of Thrombosis and Haemostasis, 2011
exaly